Blue Heron Biotechnology, Inc. has announced that it has been awarded a Phase I Small Business Innovative Research grant from the National Human Genome Research Institute.
The grant will fund research on a simple, economical and high throughput method for studying protein function.
This method will enable the production of large pools of beads with a DNA molecule on each bead and the protein or proteins encoded by that DNA molecule attached to the same bead.
"This project leverages the same technical competencies in molecular biology, chemistry and bioinformatics that we used to build the GeneMaker® gene synthesis platform,” explained Blue Heron Bio's President and CEO, John Mulligan, PhD.
“If we are successful, this new technology could be used to characterize pools of variants so that customers can rapidly improve the activity and/or stability of proteins."